Header Logo

Connection

Yahya Choonara to Excipients

This is a "connection" page, showing publications Yahya Choonara has written about Excipients.
Connection Strength

0,553
  1. Functionalised Carbon Nanotubes: Promising Drug Delivery Vehicles for Neurovascular Disorder Intervention. AAPS PharmSciTech. 2023 Oct 02; 24(7):201.
    View in: PubMed
    Score: 0,223
  2. Evaluation of the impacts of formulation variables and excipients on the drug release dynamics of a polyamide 6,10-based monolithic matrix using mathematical tools. AAPS PharmSciTech. 2013 Dec; 14(4):1349-59.
    View in: PubMed
    Score: 0,111
  3. Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS. Adv Drug Deliv Rev. 2010 Mar 18; 62(4-5):532-46.
    View in: PubMed
    Score: 0,085
  4. A novel bile salts-lipase polymeric film-infused minitablet system for enhanced oral delivery of cholecalciferol. Pharm Dev Technol. 2016 Nov; 21(7):832-846.
    View in: PubMed
    Score: 0,032
  5. A review of formulation techniques that impact the disintegration and mechanical properties of oradispersible drug delivery technologies. Pharm Dev Technol. 2016; 21(3):354-66.
    View in: PubMed
    Score: 0,030
  6. An epichlorohydrin-crosslinked semi-interpenetrating GG-PEO network as a xerogel matrix for sustained release of sulpiride. AAPS PharmSciTech. 2014 Oct; 15(5):1292-306.
    View in: PubMed
    Score: 0,029
  7. A composite polyelectrolytic matrix for controlled oral drug delivery. AAPS PharmSciTech. 2011 Mar; 12(1):227-38.
    View in: PubMed
    Score: 0,023
  8. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech. 2008; 9(2):505-20.
    View in: PubMed
    Score: 0,019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.